Freedom Capital Upgrades Abbott Laboratories (ABT) to Buy [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Earlier, on January 23, UBS reiterated a Buy rating on the stock with a $158 price target. ?The positive ratings come despite the company missing revenue estimates for its fiscal Q4 2025 earnings, released on January 22. The company grew its revenue by 4.24% year-over-year to $11.46 billion, but fell short of the consensus by $342.91 million. The EPS of $1.50 topped expectations by $0.01. ?The analysts at Freedom Capital noted that the weak results were mainly due to the weakness in the company's Nutrition segment. The firm noted that management expects this weakness to persist throughout the first half of 2026. However, the Medical Devices and Established Pharma segment of Abbott Laboratories (NYSE:ABT) continues to be the key driver of growth and is offsetting challenges in other segments. ?Freedom Capital remains optimistic on the company's future growth prospects, driven by the integration of Exact Sciences in Q2. The firm finds the company's 6.5% to 7.5% organic revenue gro
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillationPR Newswire
- ?????????????????????????????????????2035????38???????????????????????????(CAGR)?6.11%?????????? [CNET News]CNET News
- Check Your CGM: Recalled FreeStyle Libre 3 Sensors Associated With 7 Deaths [CNET News]CNET News
- Do Wall Street Analysts Like Abbott Laboratories Stock? [Yahoo! Finance]Yahoo! Finance
- AbbVie's (NYSE:ABBV) Q4 CY2025: Beats On Revenue [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 2/6/26 - Form 4
- 1/26/26 - Form 4
- 1/22/26 - Form 8-K
- ABT's page on the SEC website